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The alphavirus Semliki Forest virus (SFV) infects cells via a low pH-triggered fusion reaction mediated by the viral E1 protein. Both the
E1 fusion peptide and transmembrane (TM) domain are essential for membrane fusion, but the functional requirements for the TM domain
are poorly understood. Here we explored the role of the five TM domain glycine residues, including the highly conserved glycine pair at E1
residues 415/416. SFV mutants with alanine substitutions for individual or all five glycine residues (5G/A) showed growth kinetics and
fusion pH dependence similar to those of wild-type SFV. Mutants with increasing substitution of glycine residues showed an increasingly
more stringent requirement for cholesterol during fusion. The 5G/A mutant showed decreased fusion kinetics and extent in fluorescent lipid
mixing assays. TM domain glycine residues thus are not required for efficient SFV fusion or assembly but can cause subtle effects on the
properties of membrane fusion.
D 2004 Elsevier Inc. All rights reserved.
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Enveloped viruses use membrane fusion reactions to
introduce their genomes into the host cell and initiate
infection. Extensive studies of virus membrane fusion have
revealed a series of steps in the merger of the virus and
target membranes: close approach of the two membranes;
initial mixing of the outer leaflets of the two membranes
(termed bhemifusionQ); opening of a fusion pore, an aqueous
channel connecting the virus and target membranes; and
widening of the fusion pore to give complete and
irreversible membrane fusion (Blumenthal et al., 2003;
Chernomordik and Kozlov, 2003). Studies of these fusion
steps and correlation with conformational changes in the
virus fusion protein have uncovered critical features of the
fusion process.0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2004.11.035
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E-mail address: kielian@aecom.yu.edu (M. Kielian).Semliki Forest virus (SFV) is a member of the
alphaviruses, small enveloped RNA viruses that infect cells
via endocytosis and a low pH-triggered fusion reaction
(reviewed in Kielian, 1995; Strauss and Strauss, 1994).
Virus entry is mediated by the proteins of the SFV
membrane, an icosahedral arrangement of heterotrimers of
E1 and E2, type I transmembrane glycoproteins of
approximately 50 kDa each, and E3, a peripheral glyco-
protein of approximately 10 kDa (Schlesinger and Schle-
singer, 2001). The virus binds to receptors on the plasma
membrane via the E2 protein and is taken up by
endocytosis. Upon exposure to endosomal low pH a series
of conformational changes is triggered in the envelope
proteins. The stable but noncovalent interaction between E1
and E2 is disrupted. The released E1 protein inserts into the
cell membrane via the hydrophobic fusion peptide loop
located between amino acids 83 and 100 (Ahn et al., 2002;
Gibbons et al., 2004a). E1 undergoes a critical conforma-
tional change to form a highly stable E1 homotrimer
(Gibbons et al., 2004b). The dual association of E1 with05) 430–437
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the E1 homotrimer are believed to drive the membrane
fusion reaction. E1 membrane insertion and the SFV fusion
reaction are strongly dependent on the presence of
cholesterol in the target membrane (reviewed in Kielian et
al., 2000).
The low pH-induced conformational changes in E1 can
be effectively recapitulated using E1*, a proteolytically
truncated E1 fragment missing part of the stem region and
the entire transmembrane (TM) domain. E1* inserts into
cholesterol-containing liposomes at low pH and forms a
stable homotrimer (Gibbons and Kielian, 2002; Klimjack et
al., 1994). While the properties of the membrane-inserted
E1* homotrimer are highly similar to those of full-length E1
(Gibbons and Kielian, 2002), E1* does not trigger
membrane fusion. While tethering of E1 in the virus
membrane via the TM domain appears essential for the
complete fusion reaction, the detailed functions and
interactions of the TM domain during fusion are poorly
understood. Similar to the TM domains of many other
membrane proteins, the sequence of the alphavirus E1 TM
domain is hydrophobic and not very conserved in length or
specific sequence. Interestingly, however, the N-terminalFig. 1. Sequence analysis and mutant construction for the alphavirus E1 transmem
alphavirus E1 proteins. Amino acid begins with SFV E1. Sequence alignment of
using the program Clustal W. The position of the highly conserved glycine pair
conserved serine and tryptophan residues in the stem are also in bold. A gap (i
alignment. The GenBank accession number is listed for each alphavirus, with a
(BFV); eastern equine encephalitis virus (EEEV); Igbo Ora virus (IOV); Middelb
(SPDV); sleeping disease virus (SDV); chikungunya virus (CHIKV); o’nyong-nyo
virus (VEEV); Aura virus (AURAV); Sindbis virus (SINV); western equine enceph
(B) Amino acid sequences of the E1 transmembrane mutants constructed in thishalf of the TM domain contains a pair of glycine residues
that are highly conserved in alphavirus sequences (Fig. 1A).
Previous sequence analysis showed that glycine residues
are significantly more abundant in the TM domains of viral
fusion proteins than in those of other viral envelope proteins
(Cleverley and Lenard, 1998). This suggested that glycine
may have important functional effects on the TM domain
conformation of these proteins during fusion, perhaps by
acting to cause a kink in the TM a-helix. Studies of the
vesicular stomatitis virus (VSV) G protein suggested that at
least one of the two glycine residues in the G protein TM
domain is required for complete membrane fusion but not
for hemifusion (Cleverley and Lenard, 1998). A very recent
study of the SFV E1 protein TM domain replaced four of
the five glycine residues with leucine and described the
effects of the mutations on virus budding and fusion
(Sjoberg and Garoff, 2003).
In this study, we have used in vitro mutagenesis to
replace specific glycine residues in the TM domain of
SFV E1 with alanine residues. The mutant viruses were
assayed for their growth properties, pH- and cholesterol-
dependent fusion and fusion kinetics. Our results demon-
strate that, unlike VSV, even an SFV mutant with alaninebrane domain. (A) Sequence alignment of the transmembrane domains of
representative E1 proteins from the indicated alphaviruses was performed
is boxed, with the conserved glycine residues shown in bold. The totally
ndicated by a dash) was introduced into the SPDV sequence to optimize
bbreviations as follows: Semliki Forest virus (SFV); Barmah Forest virus
urg virus (MIDV); Ndumu virus (NDUV); salmon pancreas disease virus
ng virus (ONNV); Ross River virus (RRV); Venezuelan equine encephalitis
alitis virus (WEEV); alphavirus HBb17 (HBb17); and alphavirus M1 (M1).
study. Dots indicate sequence identity with wild-type SFV.
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growth and fusion properties similar to those of the parent
virus.Fig. 2. Growth kinetics of wt and mutant SFV in BHK cells. BHK cells
were electroporated with wt RNA or RNA from the indicated mutant and
incubated at 37 8C. The cell media were collected at the indicated times
after electroporation, and the progeny virus in the media was quantitated by
plaque assay on BHK cells.Results
Growth properties of transmembrane glycine mutants
The 3D-structure of the pH 7 E1 ectodomain of SFV
reveals that E1 is an elongated molecule with three distinct
domains, with the fusion peptide at the tip of domain II and
domain III at the opposite end of the molecule connecting to
the stem and TM domain (Lescar et al., 2001). We
performed a sequence alignment of alphavirus E1 sequences
using the program Clustal W (Fig. 1A). The alignment was
very clear-cut through the end of the ectodomain sequence
at domain III and showed several highly conserved residues
in the bstemQ region between the ectodomain and TM
domain. The SFV E1 TM domain is predicted to start
following lysine 412 and end at arginine 437. While not
every E1 sequence had these charged boundary residues,
based on the strong alignment of the preceding regions
Clustal W produces the suggested TM domain alignment
shown in Fig. 1A. This analysis identifies a highly
conserved glycine pair (SFV E1 residues 415/416) in the
N-terminal portion of the alphavirus E1 TM domain. Almost
every alphavirus sequence had this glycine pair, and those
that did not had a single glycine at this position or a closely
adjacent glycine residue. To test the role of the E1 TM
glycines, we constructed single or double mutations in the
SFV infectious clone (Liljestro¨m et al., 1991) at the
conserved glycine pair to generate three virus mutants:
G415A, G416A, and G415416A (mutants are summarized
in Fig. 1B). In addition, a bglycine-free TMQ mutant was
constructed (5G/A) with all five SFV E1 TM glycine
residues mutated to alanine.
To analyze the phenotype of the mutants, infectious
wild-type (wt) or mutant RNAs were transcribed in vitro,
introduced into BHK cells by electroporation, and the cells
cultured overnight in the presence (or absence) of 20 mM
NH4Cl to prevent secondary infection. The cells were then
fixed and infected cells quantitated by immunofluores-
cence. Primary virus infection resulting from RNA electro-
poration was observed to spread to nonelectroporated cells
in the absence of NH4Cl, and the level of secondary
infection was comparable between wt and mutants (data
not shown). To quantitate production of infectious virus,
cells were electroporated with the indicated RNAs and the
progeny virus released at each time point was determined
by plaque titration (Fig. 2). The growth kinetics of all of
the mutants were essentially identical to those of wt SFV,
showing rapid and efficient virus production already by 8
h, with the highest titer after approximately 24 h. Thus,
even the 5G/A mutations did not inhibit virus assembly or
infectivity. Purification of pyrene-labeled virus particlesfrom cells infected with wt or the 5G/A mutant (see below,
data not shown) resulted in similar yields and similar
migration of the particles in sucrose gradient sedimenta-
tion, again suggesting that assembly of the mutants was
normal.
Low pH-dependent fusion of wild-type and mutant SFV
While the absence of TM domain glycine residues did
not inhibit the overall growth of SFV, it was possible that
these mutations might have effects on the pH dependence of
the virus membrane fusion reaction. The wt SFV fusion
threshold is approximately pH 6.2, while the pH of the early
endosome in which the virus fuses has been reported to
range approximately from pH 6.5 to 5.5 (Mellman et al.,
1986). Thus, a shift in virus fusion threshold within this
range would still result in a viable virus (cf. Kielian et al.,
1984). The pH dependence of wt and mutant membrane
fusion was directly measured by quantitating the fusion of
prebound virus with the plasma membrane of BHK cells
after a 3-min treatment at the indicated pH (Fig. 3). The pH
threshold for fusion was b6.25 for both wt and mutants, and
Fig. 4. Infection of wt and mutant SFV in control and cholesterol-depleted
C6/36 cells. Control and cholesterol-depleted C6/36 cells were infected
with serial dilutions of wt SFV or the indicated mutant virus at 28 8C for
2h. Cultures were then switched to medium containing 20 mM NH4Cl to
prevent secondary infection. After further incubation for 16 h at 28 8C,
infected cells were quantitated by immunofluorescence. Virus titers were
normalized to 105 infectious centers/ml on control cells. Data shown are
the average of two independent experiments. Solid bars, infection of
control C6/36 cell; hatched bars, infection of cholesterol-depleted C6/36
cells.
Fig. 3. pH dependence of virus-membrane fusion of wt and mutant SFV. wt
and mutant SFV were incubated with BHK cells on ice for 90 min to permit
virus–cell binding. The cells were then treated with media of the indicated
pH at 37 8C for 3 min to trigger virus fusion with plasma membrane. The
cells infected due to low pH fusion were quantitated by immunofluor-
escence. Results are shown as percent maximal fusion compared to the
maximal number of infected cells at certain pH. Data are a representative
example from two independent experiments.
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3), indicating that the absence of TM glycine residues did
not significantly affect virus pH dependence. Some minor
differences were observed. While both the wt and mutant
viruses became acid inactivated and showed decreased
fusion when treated at a pH lower than 5.75, the G415416A
and 5G/A mutants were significantly more sensitive to acid
inactivation than wt SFV.
Cholesterol dependence of infection by wild-type and
mutant SFV
SFV fusion is strongly promoted by the presence of
cholesterol in the target membrane bilayer in vitro and in
vivo (Kielian et al., 2000; Phalen and Kielian, 1991; White
and Helenius, 1980). This sterol dependence is controlled
by the E1 fusion protein, and mutations in domain II of E1
can markedly decrease the cholesterol requirement for
fusion (Chatterjee et al., 2002; Lu et al., 1999; Vashishtha
et al., 1998). Cholesterol-depleted C6/36 mosquito cells
are highly refractory to alphavirus fusion and infection
(Phalen and Kielian, 1991) and were used here to compare
the sterol dependence of infection of wt SFV and the
glycine mutants in an infectious center assay. Infectivity of
wt and mutant SFV was comparable on C6/36 cells that
contain cholesterol, with both showing a somewhat lower
level (40- to 50-fold) of infectious centers on C6/36 cells
compared to plaques on BHK cells (data not shown). As
previously described, wt SFV infected cholesterol-depletedcells very poorly, with almost a 4-log decrease in
infectivity on depleted cells compared to control cells
(Fig. 4). Interestingly, the mutant viruses showed an even
stronger cholesterol requirement that was dependent on the
extent of glycine replacement. When normalized for
infectivity on cholesterol-containing C6/36 cells, the
infectivity of the single glycine mutants on sterol-depleted
cells was lower than that of wt, the double mutant
G415416A was still lower, and the 5G/A mutant was
lowest, showing about 1 log lower infectivity on choles-
terol-depleted cells compared to that of wt SFV. Infection
of cholesterol-depleted cells was greatly diminished in all
cases. However, the data suggested that the substitution of
the TM glycine residues imposed some extra hindrance on
the viral fusion reaction with target membranes that lacked
cholesterol.
Fusion kinetics of wild-type and mutant SFV with complete
liposomes in vitro
The fusion assays and infectivity assays described in
Figs. 3 and 4 reflect complete membrane fusion culminating
in the delivery of the viral nucleocapsid into the cytoplasm
of the cell. We also addressed the effect of the glycine TM
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reflect both the initial fusion of the outer membrane leaflets
and subsequent complete membrane merger. For this assay,
we followed the fusion of purified wt or 5G/A SFV that was
biosynthetically labeled with pyrene, a fluorescent fatty
acid. As discussed above, the pyrene-labeled wt and 5G/A
mutant were similar in yield and density, suggesting that the
mutant particles had a similar structure as that of wt. Fusion
of pyrene-labeled virus with unlabeled liposomes dilutes the
pyrene probe and results in the decrease of a characteristic
excimer peak, which can be followed in real time (Bron et
al., 1993; Chatterjee et al., 2000).
Fig. 5 shows the on-line fluorescence recordings of
fusion reactions for wt SFV and 5G/A at 25 and 10 8C. At
25 8C both viruses fused rapidly and efficiently, reaching
their maximal fusion extents of 65% (wt) and 54% (5G/A)
in approximately 80 s. The initial rate of wt SFV fusion
(14% fusion/s) was slightly higher than that of the 5G/A
mutant (11% fusion/s). This difference in initial fusion rates
was also evident at 10 8C (0.7% and 0.4% fusion/s for wt
and G5A, respectively), and at this temperature 5G/A again
had a lower final level of fusion (23%) than that of wt SFV
(34%). The decreased initial rate and fusion extent of the
G5/A mutant were observed in fusion assays at a range of
other temperatures (37, 30, 20, and 15 8C) (data not shown).
Comparisons of initial rates vs. temperature suggested that
the wt and 5G/A mutant have a similar dependence on
temperature (data not shown), implying that their activation
energies and overall conformational changes during mem-
brane fusion are comparable.Fig. 5. Fusion of wt and mutant SFV with liposomes. Fusion was recorded
as the real-time decrease of viral pyrene excimer fluorescence during fusion
with unlabeled liposomes. Pyrene-labeled wt or 5G/A virus (0.6 AM viral
phospholipid) was mixed with complete, cholesterol-containing liposomes
(200 AM) in buffer at pH 7.0. At time zero, the pH of the mixture was
lowered to 5.5. Curve a, wt SFVat 258; curve b, 5G/A at 25 8C; curve c, wt
SFV at 10 8C; curve d, 5G/A at 10 8C.Discussion
Similar to the TM domains of other viral and cellular
membrane proteins, the E1 TM domain sequence is not
generally conserved among members of the alphaviruses.
Thus, the presence within the TM domain of the highly
conserved glycine residues at positions 415/416 suggested
an important functional role. We demonstrate here that
neither these two conserved glycines nor any of the five
glycine residues within the TM domain were required for
fusion activity. Even the 5G/A mutant showed comparable
virus growth to that of the wt virus, reflecting efficient virus
assembly and entry. Studies of the virus cholesterol
dependence and sensitive assays of lipid mixing activity
showed that G5/Awas somewhat less efficient in fusion and
had a somewhat stronger cholesterol requirement. However,
overall the role of glycine residues in the E1 TM domain is
clearly not critical for membrane fusion.
A recent mutagenesis study of the SFV E1 TM domain
substituted the first four glycine residues (415, 416, 418,
and 426) with leucine (4L), or changed all the residues from
413 to 423 to leucine (11L) (Sjoberg and Garoff, 2003).
Both the 4L and 11L mutants were still fusion-active,
although with somewhat reduced efficiency. The 11L
mutant was also deficient in budding due to a defect in
interaction of the E2 cytoplasmic tail with the nucleocapsid.
Notably, even the more drastic 11L mutant retained a
glycine at position 435, 1 residue from the charged arginines
at 437 and 438 that are believed to represent the E1
cyoplasmic tail. Prior sequence analysis of virus fusion
proteins had revealed an overrepresentation of glycine
residues in the TM region close to the cytoplasmic side of
the membrane (Cleverley and Lenard, 1998). The work
described here replaced all of the E1 TM glycine residues
and thus demonstrated conclusively that glycine is not
required for alphavirus fusion. For the alphaviruses, it is
clear that the interaction of the E1 and E2 TM domains has
sequence specificity that is important in virus assembly and
fusion (Hernandez et al., 2003; Sjoberg and Garoff, 2003;
Strauss et al., 2002; Zhang et al., 2002). However, together
our work and the 4L and 11L mutant results argue against a
model in which glycine residues in the TM domain make a
required kink within the virus membrane during fusion.
A variety of evidence supports a critical role of the
proteinaceous membrane-spanning region of viral fusion
proteins during the membrane fusion reaction (reviewed in
Earp et al., 2004). Replacement of the TM domain of the
influenza hemagglutinin (HA) with a glycosylphosphatidy-
linositol-anchor permits lipid mixing and fusion pore
formation but blocks pore enlargement (see Markosyan et
al., 2000, and references therein). A shortened form of the
ectodomain of influenza HA2 induces low pH-dependent
lipid mixing between cells but does not form an expanding
fusion pore (Leikina et al., 2001). While the SFV E1
ectodomain inserts into target membranes via the fusion
peptide and forms the homotrimer (Ahn et al., 2002;
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(Wengler et al., 2003). Truncation studies of the TM
domains of the influenza HA and the simian immunodefi-
ciency virus fusion protein suggest that there is a minimum
length requirement for the TM domain (Armstrong et al.,
2000; West et al., 2001). The shortest TM length predicted
by our sequence alignment is 19 residues (SPDV; Fig. 1A),
longer than the 17 residues found to be essential for the
fusion function of HA.
The requirement for specific amino acid sequences
within the TM domains of virus fusion proteins is less clear
and appears more varied. Chimeric VSV G proteins
containing TM domains from nonfusion proteins are fusion
competent (Odell et al., 1997). The mutagenesis studies of
Cleverley and Lenard (1998) suggest that at least one of the
two TM glycine residues of VSV G protein plays a
significant role in the transition from hemifusion to
complete fusion. If G protein TM glycines are critical, it
suggests that the G chimeras may be active due to the
presence of glycine or other particular residues in the TM
domain of the nonfusion proteins. A recent paper on the
function of the TM domain of herpes simplex virus gH
demonstrated that a conserved glycine residue in the TM
domain is crucial for efficient fusion (Harman et al., 2002).
However, consistent with our findings in SFV E1, the gH
data show that the highly conserved glycine residue in the
central TM domain of HSV-1 is not likely to function as a
bhingeQ or helix breaker. An alanine substitution that should
stabilize helix formation was functional, while a proline
substitution that should destabilize helix formation was not
fusion active (Harman et al., 2002). Specific TM domain
requirements were also observed for charged residues in the
HIV-1 TM domain, for a specific TM glycine residue in
some strains of influenza, and for a proline in the TM
domain of the Moloney murine leukemia virus (reviewed in
Earp et al., 2004). Although this has not been studied for
each mutant, the evidence suggests that the TM sequence
requirements may act at the level of stabilizing the fusion
pore to complete the fusion reaction.
Fusion of SFV requires the presence of cholesterol in the
target membrane (Kielian et al., 2000). Our data showed that
the glycine mutants had an increasing impairment in
infectivity on cholesterol-depleted cells with progressive
substitution of the TM glycine residues, although the
mutants infected cholesterol-containing mosquito cells as
efficiently as wild-type virus. This may suggest that the
target membrane lipid composition and the altered TM
domain interact functionally to affect fusion efficiency. The
structure of the low pH-induced E1 homotrimer indicates
that the fusion peptide and the TM domain, originally at
opposite ends of E1, will be in the same membrane after
fusion (Gibbons et al., 2004b). The possible interactions of
these two hydrophobic domains with each other in the low
pH conformation are unknown, and the TM domain is not
present in the SFV E1 homotrimer structure or in the
postfusion structures of any of the fusion proteins that havebeen determined (Earp et al., 2004; Weissenhorn et al.,
1999). It is interesting to speculate that the role of the TM
domain could involve not only its function within the virus
membrane, but also its ultimate arrangement within the final
fused membrane.Materials and methods
Cells and viruses
BHK-21 cells were maintained at 37 8C in Dulbecco’s
modified Eagle’s medium (DME) containing 100 U of
penicillin/ml and 100 Ag of streptomycin/ml (P/S), 5% fetal
calf serum (FCS), and 10% tryptose phosphate broth
(Phalen and Kielian, 1991). Control cholesterol-containing
C6/36 mosquito cells were cultured at 28 8C in DME with
P/S and 10% heat-inactivated FCS (Marquardt et al., 1993).
Cholesterol-depleted C6/36 cells were prepared by 4–15
passages at 28 8C in DME containing P/S and 10%
delipidated heat-inactivated FCS (Marquardt and Kielian,
1996; Phalen and Kielian, 1991). The levels of both free and
esterified cholesterol in the cholesterol-depleted cells were
less than 2% of those of control cells (Phalen and Kielian,
1991). The wt SFV used in this study was prepared from the
pSP6-SFV4 infectious clone (Liljestro¨m et al., 1991).
In vitro mutagenesis and generation of virus stocks
The mutations were introduced into the pSP6-SFV4
infectious clone by PCR mutagenesis using Pfu Turbo DNA
polymerase (Stratagene, La Jolla, CA) and either the overlap
extension method (Vashishtha et al., 1998) or circular
mutagenesis of a plasmid encoding E1, 6K, and the C-
terminal half of E2 (Chanel-Vos and Kielian, 2004).
Mutagenic primer pairs were designed not only to carry
the desired mutations (Fig. 1B) but also to insert a new
restriction enzyme digestion site for an initial screen of
mutant infectious clones. Unique NsiI and SpeI sites were
used to subclone the mutations into the pSP6-SFV4
infectious clone, and the E1 TM region from each mutant
infectious clone was sequenced to confirm the presence of
the desired mutations and the absence of other mutations. To
generate wt and mutant SFV stocks, infectious clones were
linearized by SpeI digestion, infectious RNAs were tran-
scribed in vitro and introduced into BHK cells by electro-
poration, the cells were cultured for approximately 24 h at
37 8C, and the progeny virus-containing medium was
harvested (Vashishtha et al., 1998).
Assays of virus growth, membrane fusion activity, and the
cholesterol dependence of infection
To compare the growth kinetics of mutant and wt SFV,
BHK cells were electroporated with wt or mutant RNA and
cultured at 37 8C for up to 24 h. The cell media were
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amount of infectious virus in the media was determined by
plaque assay on BHK cells.
The fusion activity of wt and mutant virus stocks was
measured by prebinding serial dilutions of virus to BHK
cells on ice with shaking for 90 min. The cells with bound
virus were then treated at the indicated pH for 3 min at 37
8C to trigger virus fusion with plasma membrane. Twenty-
millimolar NH4Cl was included in the media to neutralize
endosomal low pH and prevent fusion via the normal
pathway of endocytic uptake. The cells were then incubated
for approximately 16 h at 28 8C in medium containing 20
mM NH4Cl to prevent secondary infection, and the cells
infected due to low pH-triggered fusion were quantitated by
immunofluorescence, all as described in Zhang et al. (2003).
No background infection was observed in cells treated for 3
min at pH 7.0, and thus infection at low pH reflected fusion
with the plasma membrane.
To evaluate the cholesterol dependence of infection,
control and cholesterol-depleted C6/36 mosquito cells were
infected with serial dilutions of wt or mutant SFV at 28 8C
for 2 h, cultured for approximately 16 h at 28 8C in medium
containing 20 mM NH4Cl to prevent secondary infection,
and the infected cells quantitated by immunofluorescence
(Vashishtha et al., 1998).
Preparation of pyrene-labeled viruses
Pyrene-labeled wt and mutant viruses were prepared
essentially as previously described (Bron et al., 1993;
Chatterjee et al., 2000). In brief, BHK cells were cultured
for 15 h in 850-cm2 roller bottles in BHK medium as
described above. Cellular phospholipids were labeled by
growth for 24 h in the presence of C16-pyrene (Molecular
Probes, Eugene, OR) at a final concentration of 10 Ag/ml.
The cells were then infected with wt SFV or 5G/A at a
multiplicity of 5 PFU/cell for 24 h in medium without
pyrene. The labeled virus was purified by banding on a
discontinuous sucrose gradient and aliquots stored at 80
8C until use. The pyrene excimer–monomer ratio was
determined for each virus preparation by exciting at 343
nm at 37 8C and recording the emitted fluorescence at 470
nm (excimer) and 372 nm (monomer) using an Aminco-
Bowman AB-2 fluorometer (Spectronic Unicam, Rochester,
NY). The excimer–monomer ratios were 0.214 and 0.205
for wt SFV and mutant 5G/A, respectively.
Virus–liposome fusion assay
Large unilamellar vesicles were prepared by freeze–thaw
and extrusion as previously described (Chatterjee et al.,
2002; Corver et al., 1997). The bcompleteQ liposomes used
in this study contained a 1:1:1:1.5 molar ratio of phospha-
tidylcholine (PC; from egg yolk), phosphatidylethanolamine
(PE; prepared from egg PC by transphosphatidylation),
sphingomyelin (Sph; from bovine brain), and cholesterol(Chatterjee et al., 2002). Lipid mixing during SFV–lip-
osome fusion was assayed by monitoring the decrease in
virus pyrene excimer fluorescence (Bron et al., 1993;
Chatterjee et al., 2002). The virus–liposome mixture was
stirred continuously in a thermostatted cuvette at the
indicated temperature and fusion was triggered by the
addition of a pretitrated volume of 0.3 M MES (pH 4.8) to
give a final pH of 5.5. Pyrene excimer fluorescence was
measured in an AB-2 fluorometer using excitation and
emission wavelengths of 343 and 480 nm, respectively, with
a 470-nm cutoff filter in the emission beam. The 0% fusion
level was set at the initial excimer fluorescence, and the
100% fusion level was defined as the fluorescence upon
addition of the detergent C12E8. Fusion rates were measured
from the steepest part of the fusion curves after the lag time,
using time intervals of 1.5–3 s for 25 8C and 10.5–34.5 s for
10 8C. Rates are taken from the average of at least two
independent fusion assays.Acknowledgments
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